These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 7922469)

  • 1. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.
    Wenning GK; Ben Shlomo Y; Magalhães M; Daniel SE; Quinn NP
    Brain; 1994 Aug; 117 ( Pt 4)():835-45. PubMed ID: 7922469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grading of neuropathology in multiple system atrophy: proposal for a novel scale.
    Jellinger KA; Seppi K; Wenning GK
    Mov Disord; 2005 Aug; 20 Suppl 12():S29-36. PubMed ID: 16092088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations.
    Ozawa T; Paviour D; Quinn NP; Josephs KA; Sangha H; Kilford L; Healy DG; Wood NW; Lees AJ; Holton JL; Revesz T
    Brain; 2004 Dec; 127(Pt 12):2657-71. PubMed ID: 15509623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to L-DOPA in multiple system atrophy.
    Parati EA; Fetoni V; Geminiani GC; Soliveri P; Giovannini P; Testa D; Genitrini S; Caraceni T; Girotti F
    Clin Neuropharmacol; 1993 Apr; 16(2):139-44. PubMed ID: 8477409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electro-oculogram in multiple system and late onset cerebellar atrophies.
    Arpa J; Sarriá J; Cruz-Martínez A; López-Pajares R; Ferrer T; Palomo F; Alonso M; Vivancos F; Nos J; Iváñez V
    Rev Neurol; 1995; 23(123):969-74. PubMed ID: 8556607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Striatonigral degeneration and sporadic olivopontocerebellar atrophy: a consideration of the clinical entity of multiple system atrophy].
    Miwa H; Kondo T; Mizuno Y
    No To Shinkei; 1999 Apr; 51(4):305-12. PubMed ID: 10363264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micturitional disturbance in multiple system atrophy.
    Sakakibara R; Hattori T; Tojo M; Yamanishi T; Yasuda K; Hirayama K
    Jpn J Psychiatry Neurol; 1993 Sep; 47(3):591-8. PubMed ID: 8301874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems.
    Inoue M; Yagishita S; Ryo M; Hasegawa K; Amano N; Matsushita M
    Acta Neuropathol; 1997 Jun; 93(6):585-91. PubMed ID: 9194897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple system atrophy. Clinical and MR observations on 42 cases.
    Testa D; Savoiardo M; Fetoni V; Strada L; Palazzini E; Bertulezzi G; Girotti F
    Ital J Neurol Sci; 1993 Apr; 14(3):211-6. PubMed ID: 8314674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple system atrophy: a review of 203 pathologically proven cases.
    Wenning GK; Tison F; Ben Shlomo Y; Daniel SE; Quinn NP
    Mov Disord; 1997 Mar; 12(2):133-47. PubMed ID: 9087971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease.
    Colosimo C; Albanese A; Hughes AJ; de Bruin VM; Lees AJ
    Arch Neurol; 1995 Mar; 52(3):294-8. PubMed ID: 7872884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease--a retrospective comparison.
    Magalhães M; Wenning GK; Daniel SE; Quinn NP
    Acta Neurol Scand; 1995 Feb; 91(2):98-102. PubMed ID: 7785431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Pure" striatonigral degeneration and Parkinson's disease: a comparative clinical study.
    Gouider-Khouja N; Vidailhet M; Bonnet AM; Pichon J; Agid Y
    Mov Disord; 1995 May; 10(3):288-94. PubMed ID: 7651445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA.
    Yabe I; Soma H; Takei A; Fujiki N; Yanagihara T; Sasaki H
    J Neurol Sci; 2006 Nov; 249(2):115-21. PubMed ID: 16828805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological study of 35 cases of multiple system atrophy.
    Wenning GK; Ben-Shlomo Y; Magalhães M; Daniel SE; Quinn NP
    J Neurol Neurosurg Psychiatry; 1995 Feb; 58(2):160-6. PubMed ID: 7876845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple system atrophy (MSA)].
    Moriwaka F; Tashiro K
    Nihon Rinsho; 1993 Nov; 51(11):2952-6. PubMed ID: 8277576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain in multiple system atrophy.
    Tison F; Wenning GK; Volonte MA; Poewe WR; Henry P; Quinn NP
    J Neurol; 1996 Feb; 243(2):153-6. PubMed ID: 8750553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further characterization of autonomic involvement in multiple system atrophy: a pupillometric study.
    Micieli G; Tassorelli C; Martignoni E; Marcheselli S; Rossi F; Nappi G
    Funct Neurol; 1995; 10(6):273-80. PubMed ID: 8837991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
    Perani D; Bressi S; Testa D; Grassi F; Cortelli P; Gentrini S; Savoiardo M; Caraceni T; Fazio F
    Arch Neurol; 1995 Feb; 52(2):179-85. PubMed ID: 7848128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of patients with multiple system atrophy.
    Saito Y; Matsuoka Y; Takahashi A; Ohno Y
    Intern Med; 1994 Jun; 33(6):321-5. PubMed ID: 7919616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.